Medicare billing address
CMS Medicare provider billing file
1250 S Cedar Crest BlvdSte 205
Allentown, PA 18103
CMS public data · NPI 1720352016
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Andres Zirlinger, MD
Specialty
Credential
MD
NPI
1720352016
Primary source state
PA
Data retrieval date
July 26, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Andres Zirlinger, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
1250 S Cedar Crest BlvdCMS Doctors & Clinicians file
1107 Grosser RdCMS Doctors & Clinicians file
1107 Grosser Rd 3Rd FloorCMS Doctors & Clinicians file
1109 Grosser RdIn the 2024 CMS provider billing file, this NPI had 662 Medicare beneficiaries and 1,560 total services. The average beneficiary age was 74, and the average HCC risk score was 2.1.
Total Medicare allowed amount
$98,846.71
Total Medicare payment amount
$76,651.97
Medicare beneficiaries
662
Total services
1,560
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
COPD
50%
CMS beneficiary-panel share
Ischemic heart disease
47%
CMS beneficiary-panel share
Chronic kidney disease
42%
CMS beneficiary-panel share
Mood disorders
40%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Critical care, first 30-74 minutes | 285 | $198.75 |
| Test to examine how well the lungs exchange gases | 258 | $8.14 |
| Test to determine lung volumes using sensors | 247 | $10.97 |
| Test to measure rate of airflow | 170 | $13.24 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 108 | $9.30 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 75 | $74.73 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 68 | $121.31 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 55 | $81.58 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 46 | $15.01 |
| Test for exercise-induced lung stress | 24 | $20.87 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1720352016. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 151 | 217 | $135,296.69 |
| 2 | Albuterol Sulfate Hfa | Albuterol Sulfate | 132 | 189.9 | $4,840.86 |
| 3 | Spiriva Respimat | Tiotropium Bromide | 87 | 125 | $62,697.66 |
| 4 | Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 68 | 112 | $13,474.15 |
| 5 | Montelukast Sodium | Montelukast Sodium | 61 | 141.3 | $641.58 |
| 6 | Incruse Ellipta | Umeclidinium Bromide | 51 | 87 | $28,879.64 |
| 7 | Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 39 | 55 | $9,796.66 |
| 8 | Breo Ellipta | Fluticasone/Vilanterol | 31 | 39 | $14,529.96 |
| 9 | Dupixent Pen | Dupilumab | 31 | 31 | $106,623.37 |
| 10 | Prednisone | Prednisone | 31 | 31 | $68.18 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Graduation year
2004
Group/practice field
Lehigh Valley Physician Group
Telehealth reported
Yes
Secondary specialty fields reported by CMS: Pulmonary Disease.
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.